Catalyst Wire Dossier Catalyst Wire Dossier

Zunrisa

casopitant mesilate · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Zunrisa, covering 2009-10-13 to 2009-10-13. Get the full timeline:

Most recent: GlaxoSmithKline withdraws its marketing authorisation application for Zunrisa (casopitant mesilate)

See pricing